|
|
|
|
|
Detail |
| hsa-miR-21 |
|
Unspecified |
A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNAs play an essential role in the development of cardiac hypertrophy. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Patterns of known and novel small RNAs in human cervical cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Expression profiling identifies microRNA signature in pancreatic cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNAs: novel regulators involved in the pathogenesis of Psoriasis? |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
The role of microRNA genes in papillary thyroid carcinoma. |
2005 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
miR-21-mediated tumor growth. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. |
2005 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
Cholesteatoma Growth and Proliferation: Posttranscriptional Regulation by MicroRNA-21. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
Distinct microRNA alterations characterize high- and low-grade bladder cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA expression profiles in serous ovarian carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA expression profiles of esophageal cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA expression and identification of putative miRNA targets in ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Heterogeneous dysregulation of microRNAs across the autism spectrum. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
miR-21 microRNA expression in human gastric carcinomas and its clinical association. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.
|
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
A microRNA expression ratio defining the invasive phenotype in bladder tumors. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
Association between High miR-211 microRNA Expression and the Poor Prognosis of Oral Carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA alterations in head and neck squamous cell carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell
carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
The expression profile of microRNAs in a model of
7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Microarray analysis of microRNA expression in renal clear cell carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
Antisense Inhibition of microRNA-21 or -221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Alteration of microRNA expression in vinyl-carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas |
2009 |
|
|
|
|
|
|